BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
Earnings News on Aurobindo Pharma
Aurobindo Pharma Q3 cons PAT at Rs 91.8cr
7.24 pm | 07 Feb 2013 | Source: CNBC-TV18
Aurobindo Pharma has declared its third quarter results. The company's Q3 consolidated net profit was up at Rs 91.8 crore versus loss of Rs 28.5 crore...
Quick Links for Aurobindo Pharma
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.